We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 7,809 results
  1. Immediate and Delayed Hypersensitivity Reactions to Antibiotics: Aminoglycosides, Clindamycin, Linezolid, and Metronidazole

    Hypersensitivity reactions including IgE-mediated and delayed cell-mediated reactions to aminoglycosides, clindamycin, linezolid, and metronidazole...

    Michelle Dilley, Bob Geng in Clinical Reviews in Allergy & Immunology
    Article Open access 15 December 2021
  2. Aminoglycoside-Related Nephrotoxicity and Ototoxicity in Clinical Practice: A Review of Pathophysiological Mechanism and Treatment Options

    Aminoglycosides are a class of medications used to treat certain bacterial infections, specifically gram-negative aerobes. These drugs can be used...

    Tyler A. Le, Tasneem Hiba, ... Alan D. Kaye in Advances in Therapy
    Article 04 February 2023
  3. Species identification and drug susceptibility testing of non-tuberculous mycobacteria by Line Probe Assay in Lambaréné, Gabon—a cross-sectional study

    Background

    Non-tuberculous mycobacteria (NTM) are a group of bacteria that cause rare lung infections and are increasingly recognized as causative...

    Micheska Epola Dibamba Ndanga, Jabar Babatundé Pacome Achimi Agbo Abdul, ... Ayola Akim Adegnika in BMC Infectious Diseases
    Article Open access 03 October 2023
  4. Aminoglycosides for the treatment of septic shock: a propensity-based study

    Jean-François Llitjos, Simon Meslin, ... Frédéric Pène in Critical Care
    Article Open access 21 September 2020
  5. Ototoxic and nephrotoxic drugs in neonatal intensive care units: results of a Spanish and Italian survey

    Neonates face heightened susceptibility to drug toxicity, often exposed to off-label medications with dosages extrapolated from adult or pediatric...

    Cristina Arribas, Nunzia Decembrino, ... Felipe Garrido in European Journal of Pediatrics
    Article 16 March 2024
  6. Efficacy of carbapenem vs non carbapenem β-lactam therapy as empiric antimicrobial therapy in patients with extended-spectrum β-lactamase-producing Enterobacterales urinary septic shock: a propensity-weighted multicenter cohort study

    Background

    The rise in antimicrobial resistance is a global threat responsible for about 33,000 deaths in 2015 with a particular concern for...

    Erwann Cariou, Romain Griffier, ... Alexandre Boyer in Annals of Intensive Care
    Article Open access 24 March 2023
  7. Antimicrobial utilization and resistance in Pseudomonas aeruginosa using segmented regression analysis: a comparative study between Serbia and eight European Countries

    Background

    In Europe, Serbia occupies a high position in antibiotic utilization and antimicrobial resistance (AMR).

    Aim

    The aim was to analyse...

    Tanja Tomic, Martin Henman, ... Marina Odalovic in International Journal of Clinical Pharmacy
    Article 07 June 2023
  8. Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems

    The management of carbapenem-resistant infections is often based on polymyxins, tigecycline, aminoglycosides and their combinations. However, in a...

    Stamatis Karakonstantis, Evangelos I Kritsotakis, Achilleas Gikas in Infection
    Article 01 September 2020
  9. Neonatal nephrotoxic medication exposure and early acute kidney injury: results from the AWAKEN study

    Background

    We aimed to describe nephrotoxic medication exposure and investigate associations between exposure and acute kidney injury (AKI) in the...

    Heidi J. Steflik, Jennifer R. Charlton, ... Shanthy Sridhar in Journal of Perinatology
    Article 26 April 2023
  10. Prevalence and mechanisms of aminoglycoside resistance among drug-resistant Pseudomonas aeruginosa clinical isolates in Iran

    Background

    Aminoglycosides have been a cornerstone of the treatment of nosocomial infections caused by Pseudomonas aeruginosa for over 80 years....

    Nilofar Saeli, Saghar Jafari-Ramedani, ... Farzad Khademi in BMC Infectious Diseases
    Article Open access 09 July 2024
  11. International survey of antibiotic dosing and monitoring in adult intensive care units

    Background

    In recent years, numerous dosing studies have been conducted to optimize therapeutic antibiotic exposures in patients with serious...

    Paul G. Williams, Alexis Tabah, ... Peter Schellongowski in Critical Care
    Article Open access 19 June 2023
  12. Optimization of Pediatric Antibiotic Dosing Through Therapeutic Drug Monitoring

    Purpose of review

    Review data and provide recommendations on the optimization of antibiotic dosing in pediatrics through therapeutic drug monitoring...

    Article 03 October 2022
  13. Assessment of Causality in Hospitalized Children With Aminoglycoside-Related Nephrotoxicity

    Objectives

    To evaluate the incidence of aminoglycoside-related nephrotoxicity and ascertain drug causality and its risk factors.

    Methods ...
    Madhileti Sravani, Sriram Krishnamurthy, ... Medha Rajappa in Indian Pediatrics
    Article 05 January 2022
  14. Dynamic antimicrobial resistant patterns of Escherichia coli from healthy poultry and swine over 10 years in Chongming Island, Shanghai

    Background

    Antimicrobial resistance (AMR) is one of the greatest threats to animal and public health. Here, we conducted a dynamic surveillance of Esch...

    Chao Lv, Jun Shang, ... Yongzhang Zhu in Infectious Diseases of Poverty
    Article Open access 16 September 2022
  15. Ouabain potentiates the antimicrobial activity of aminoglycosides against Staphylococcus aureus

    Background

    Staphylococcus aureus is a notorious pathogen which often causes nosocomial and community attained infections. These infections steadily...

    Neelam Kumari, Snehlata Singh, ... Antresh Kumar in BMC Complementary and Alternative Medicine
    Article Open access 06 June 2019
  16. Clinical characteristics and outcomes in pseudomonas endocarditis: a systematic review of individual cases

    Background

    The landscape of Pseudomonas infective endocarditis (IE) is evolving with the widespread use of cardiac implantable devices and...

    Durga Shankar Meena, Deepak Kumar, ... Mahendra Kumar Garg in Infection
    Article 10 June 2024
  17. Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study

    Introduction

    Extensively drug-resistant (XDR) Pseudomonas aeruginosa (PA) infections are difficult to treat. We aimed to compare aminoglycosides or...

    Inmaculada López Montesinos, Silvia Gómez-Zorrilla, ... Juan Pablo Horcajada in Infectious Diseases and Therapy
    Article Open access 03 December 2021
Did you find what you were looking for? Share feedback.